Injectable magnesium-bisphosphonate MOF-based bone adhesive prevents excessive fibrosis for osteoporotic fracture repair
Abstract Current treatments for osteoporotic fractures primarily target bone-resorbing osteoclasts, but they often fail to address fibrosis—a buildup of fibrous tissue that disrupts bone healing. This fibrosis is frequently triggered by bisphosphonates, which, while effective in reducing bone loss,...
Saved in:
| Main Authors: | Tianhua Xiao, Zunlei Gong, Dongming Duan, Hui Yu, Song Liu, Yuhe Jiang, Xudan Xing, Zenghui Wu, Le Wang, Xuebin B. Yang, Giuseppe Tronci, Chengyun Ning, Guoxin Tan, Lei Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-60853-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
glucocorticoid osteoporosis; osteoporotic fracture; bisphosphonates; FRAX algorithm
by: Natalia Vladimirovna Toroptsova, et al.
Published: (2013-12-01) -
Time since last intravenous bisphosphonate and risk of osteonecrosis of the jaw in osteoporotic patients
by: Jung-Hyun Park, et al.
Published: (2025-05-01) -
Assessment Results of Dental Students' Knowledge about Bisphosphonates and Bisphosphonate-Related Osteonecrosis of the Jaw
by: Greta Sereikaite, et al.
Published: (2023-12-01) -
The art of treating osteoporosis: Bisphosphonates
by: Sergey Olegovich Mazurenko
Published: (2012-03-01) -
The use of bisphosphonates for the treatment and prevention of osteoporosis
by: O. A. Nikitinskaya, et al.
Published: (2022-08-01)